Results 11 to 20 of about 27,665 (215)

PHARMACOEPIDEMIOLOGY IN THE ASSORTMENT POLICY-PRODUCER OF DRUGS

open access: yesФармация и фармакология (Пятигорск), 2015
RETRACTED ARTICLEThe analysis of the range of the medicines presented by the pharmaceutical company «Servier » in the Russian market, applied is carried out at treatment of a wide range of diseases.
V. Y. Krasnov
doaj   +2 more sources

PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE

open access: yesФармакоэкономика, 2015
pharmacoepidemiology is a well recognized throughout the world scientific discipline studying the use of and the effects of drugs in the whole population or in large groups of people in order to improve efficacy and safety of pharmacotherapy. Despite its
S. A. Rachina   +2 more
doaj   +1 more source

ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY

open access: yesФармакоэкономика, 2015
: pharmacoepidemiology has recently evolved into a self-dependent post-marketing disciplinefrom clinical pharmacology, borrowing its methodology and analyticaltools from epidemiology.
T. L. Galankin, A. S. Kolbin
doaj   +1 more source

How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias [PDF]

open access: yes, 2020
Several pharmacoepidemiology networks have been developed over the past decade that use a distributed approach, implementing the same analysis at multiple data sites, to preserve privacy and minimize data sharing.
Henry, DA   +17 more
core   +3 more sources

The Norwegian Society for Pharmacoepidemiology [PDF]

open access: yes, 2021
The Norwegian Society for Pharmacoepidemiology (NFFE) is a multidisciplinary, nation-wide network of professionals involved in the field of pharmacoepidemiology.
Olsen, Kristine   +6 more
core   +1 more source

Clinical epidemiology and pharmacoepidemiology studies with real-world databases [PDF]

open access: yes, 2022
Hospital-based registry data, including patients’ information collected by academic societies or government based research groups, were previously used for clinical research in Japan.
TANAKA-MIZUNO, Sachiko   +6 more
core   +2 more sources

Investigação em farmacoepidemiologia de campo: uma proposta para as ações de farmacovigilância no Brasil Investigation in field pharmacoepidemiology: a proposal for the actions of pharmacovigilance in Brazil

open access: yesRevista Brasileira de Epidemiologia, 2011
O presente artigo tem como objetivos propor e descrever a investigação em farmacoepidemiologia de campo como função primordial de farmacovigilância a ser conduzida pelas vigilâncias sanitárias municipais, estaduais e/ou federal frente à notificação ...
Daniel Marques Mota
doaj   +1 more source

The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). [PDF]

open access: yes, 2018
In pharmacoepidemiology, routinely collected data from electronic health records (including primary care databases, registries, and administrative healthcare claims) are a resource for research evaluating the real world effectiveness and safety of ...
Sturkenboom, Miriam   +30 more
core   +3 more sources

Identifying Surgical and Trauma Patients in New Zealand for Opioid-Related Pharmacoepidemiological Research: A Descriptive Study

open access: yesPharmacoepidemiology, 2022
Unique aspects of New Zealand’s (NZ) health system allow for a novel pharmacoepidemiologic approach to conducting population-based clinical research. A defined cohort of surgical and trauma patients would facilitate future studies into opioid utilisation,
Jiayi Gong   +5 more
doaj   +1 more source

A Catalogue of Dispensation Lengths for Building Treatment Episodes-Application of the Waiting Time Distribution to All Commonly Prescribed Drugs in Denmark. [PDF]

open access: yesPharmacoepidemiol Drug Saf
ABSTRACT Background In pharmacoepidemiologic research, correct assignment of the length of single dispensation is critical to build treatment episodes. The parametric reverse waiting time distribution (rWTD) is a particularly attractive data‐driven method to estimate dispensation lengths.
Reilev M   +8 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy